EQS-News: invIOs GmbH / Key word(s): Study invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant
EQS-News: Biotest AG / Key word(s): Study Biotest AG: Biotest treats first shingles patient with Varitect® CP in VARIZOSTA study 05.09.2023 / 09:00 CET/CEST The
EQS-News: iOmx Therapeutics AG / Key word(s): Personnel iOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business Officer 05.09.2023 / 08:30 CET/CEST The issuer
EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous DEFENCE’S INNOVATIVE THERAPEUTICS FEATURED ON VIEWPOINT WITH DENNIS QUAID 05.09.2023 / 08:00 CET/CEST The issuer is solely
Biophytis / Key word(s): Conference/Conference Biophytis to Participate at the H.C. Wainwright 25th Global Investment Conference in New York 04-Sep-2023 / 23:00 CET/CEST Biophytis
Illinois adult-use cannabis sales in August were down a bit sequentially to $139.2 million, a decline of 0.6% from July. The gain was 7.6% from a year